Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies
Toxicologic Pathology · 2025-08 · 53 (6) · 571-581
DOI: 10.1177/01926233251339113 ↗Kurz gefasst
Fachartikel in der Zeitschrift Toxicologic Pathology, online erschienen am 31.05.2025. Verfasst von Lila Ramaiah und 6 weiteren Autor:innen. Beteiligte Einrichtung: Johnson & Johnson, Spring House, Pennsylvania, USA. Hauptthemen laut MEDLINE: Toxicology, Pathology, Pathology, Clinical, Toxicity Tests. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 80 Literaturangaben.
Abstract (Originalsprache)
Toxicologic pathologists assess large data sets from nonclinical studies to identify treatment-related effects to assist in predicting human safety hazards. Statistical testing can facilitate data interpretation by highlighting group differences that have a low probability of random occurrence based on a pre-determined P -value cut-off (eg, P < .05). While this method has been used in the interpretation of pathology data for decades, the appropriateness of utilizing statistical testing in this way has been challenged. Here, we discuss common statistical pitfalls in the analysis of toxicologic pathology data, with emphasis on clinical pathology, reaffirming that appropriate use of statistical analysis requires an understanding of (1) the parameters assessed; (2) the inherent strengths and weaknesses of the statistical method used; and (3) that appropriate interpretation of pathology data is based on the pathologist’s expertise. The presence or absence of statistical significance should not supersede expert judgment but should be one of many tools used to reach a conclusion.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Johnson & Johnson, Spring House, Pennsylvania, USA.
- AltaSciences Preclinical, Seattle, Washington, USA.
- IQVIA, Reading, UK.
- Vertex Pharmaceuticals, Boston, Massachusetts, USA.
- MD Anderson Cancer Center, Houston, Texas, USA.
- Independent Statistical Consultant (ret.), Underhill, Vermont, USA.
ORCID-Profile: Lila Ramaiah, Tara Arndt, Gareth Thomas, Norimitsu Shirai, Manu Sebastian, Cory Sims, Steven Bailey
Zitieren
APA
Ramaiah, L., Arndt, T., Thomas, G., Shirai, N., Sebastian, M., Sims, C., & Bailey, S. (2025). Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies. Toxicologic Pathology, 53(6), 571-581. https://doi.org/10.1177/01926233251339113
Vancouver
Ramaiah L, Arndt T, Thomas G, Shirai N, Sebastian M, Sims C, et al. Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies. Toxicologic Pathology. 2025;53(6):571-581. doi:10.1177/01926233251339113
BibTeX
@article{Ramaiah2025,
author = {Ramaiah, Lila and Arndt, Tara and Thomas, Gareth and Shirai, Norimitsu and Sebastian, Manu and Sims, Cory and Bailey, Steven},
title = {Toxicologic Pathology Forum*: Opinion on the Interpretation of Statistical Significance Testing Results From Anatomic and Clinical Pathology Data in Nonclinical Safety Studies},
journal = {Toxicologic Pathology},
year = {2025},
volume = {53},
number = {6},
pages = {571--581},
doi = {10.1177/01926233251339113}
}
EUVIMED